key: cord-287373-7xjn05k8
authors: Lian, Xin; Shen, Jing; Sun, Yuliang; Guan, Qiu; Pang, Tingtian; Yang, Zhiwei; He, Lei; Dong, Tingting; Shen, Jie; Zhang, Fuquan
title: Under the coronavirus disease 2019(COVID-19) pandemic circumstance, how to administrate cancer patients with fever during radiotherapy
date: 2020-06-05
journal: Radiother Oncol
DOI: 10.1016/j.radonc.2020.05.049
sha: 
doc_id: 287373
cord_uid: 7xjn05k8

nan

2.The screen process of patient with fever during radiotherapy in the center.

All fever patients were screened by fever clinic with COVID 2019 nucleic acid, Patients with fever had been suspended from radiation therapy until the outcome of negative screen test results and the relive of fever symptoms, the average duration of suspension was 5.5 days (3-11), see figure 2 for details.

During the covid-19 pandemic, the center has added free online consultation In summary, for cancer patients receiving radiotherapy, especially for lung cancer patients, old age, late disease staging, combined with cardiovascular or cerebrovascular diseases and combined with chemotherapy, leukocyte abnormality and hypoalbuminemia as a cause of fever are more likely to happen during radiotherapy. It is suggested that fever patients with anti-tumor therapy during COVID-19 epidemic should carefully be concerned. In order to ensure the safety treatment for these patients and other patients without fever, fast and effective screening and patient management are necessary. Scientific and reasonable arrangements for the treatment and strict screen procedure for fever patient will ensure the maximization of the rights and interests of cancer patients. We believe our approach can provide a good reference for other radiotherapy centers, especially for COVID-19 similar regions. The fever clinic to screen *The line ( )shows the delay of radiation treatment, with the unit of day, the longer of the line, the more days for treatment delay. 6 patients (21.4%)with urinary tract infection delayed 7.5 days(4-11), 8 patients (28.5%)with pulmonary inflammatory infection delayed 6 days(4-9), 4 patients (14.2%)with gastrointestinal infection delayed 5.25 days(4-7), 9 patients (32.1%)with tumor fever delayed 3.8 days(3-7). As the average delay duration of radiotherapy is 5.5 days (3) (4) (5) (6) (7) (8) (9) (10) (11) .

Clinical Characteristics and Coping Strategies of Neoplasms with 2019 Novel Coronavirus Infection

Risk of COVID-19 for patients with cancer

COVID-19 outbreak and cancer patient management: viewpoint from radio-oncologists